Intel Corp. INTC stock has been heading for its best week since January 2000, largely driven by vocal support from President Donald Trump.

TROW's AUM rises 1.6% in July 2025 to $1.70T, with gains across equity, fixed income, multi-asset and alternative products.

A potential deal with the Trump administration is shaping up to be a saving grace for Intel (INTC), which saw its shares climb Friday while other semiconductor stocks slid.

ARM's renewed growth efforts are likely to be rather expensive, attributed to the intensified R&D investments and the speculative M&A activities. This is on top of the potentially prolonged monetization cadence and the intense market competition, as the company lags its more successful legacy chip peers. While ARM's future potential may be immense, we are already seeing growth pains in its impacted profit margins/ adj EPS, with it well negating the higher royalty opportunities.

BENSALEM, Pa., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

As Intel's stock heads for its biggest weekly gain in 50 years, analysts wonder if the U.S. government can really help the company fix its technological issues.

Shareholders with losses of $100,000 or more are encouraged to contact the firm. LOS ANGELES, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 16, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG) common stock between January 5, 2023 and June 3, 2025, inclusive (the “Class Period”).

Ulta Beauty and Target just announced they won't renew their five-year partnership after reaching 600 Ulta-Target shop-in-shops, falling short of their original goal of 800 locations. With the partnership ending in August 2026, Target's got a year to prepare to dismantle the Ulta in-store concessions, which can span up to 1,000 square feet, and repurpose the space.

Chief Executive Carrie Wheeler has stepped down, and investors are happy.

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 10, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025, inclusive (the “Class Period”). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SELECTQUOTE, INC. (SLQT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE IN THE ON.

I rate Vistra Corp (VST) a Buy due to AI-driven power demand, robust fundamentals, and significant growth opportunities in the evolving energy landscape. VST benefits directly from surging data center and semiconductor fab electricity needs, as hyperscalers ramp up capital investment for AI and cloud projects. Strong partnerships and dispatchable generation assets, including nuclear, position VST as a reliable power supplier for tech companies seeking long-term contracts.

LOS ANGELES, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming September 22, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired RxSight, Inc. (“RxSight” or the “Company”) (NASDAQ: RXST) securities between November 7, 2024 and July 8, 2025, inclusive (the “Class Period”).

Cidara Therapeutics, Inc.'s CD388's strong phase 2b results significantly de-risk CDTX and highlight its potential as a superior flu prophylactic, especially for high-risk patients. Multiple short-term catalysts—including FDA meeting, BARDA funding, potential early start of phase 3 and breakthrough designation—could accelerate development and drive further upside. Cidara is well-funded through phase 3, with $516.9M in cash, and is an attractive acquisition candidate after its impressive trial results.

International Flavors debuts POWERFRESH ACE 2000, a bread enzyme that boosts softness, extends shelf life and supports bakery sustainability goals.

The long-running mystery around Warren Buffett's latest stealth investment is finally over. In Berkshire Hathaway's NYSE: BRK.B newest 13F filing, the Oracle of Omaha revealed a fresh stake in UnitedHealth Group Incorporated NYSE: UNH.

On 8/19/25, Chevron will trade ex-dividend, for its quarterly dividend of $1.71, payable on 9/10/25. As a percentage of CVX's recent stock price of $155.16, this dividend works out to approximately 1.10%, so look for shares of Chevron to trade 1.10% lower — all else being equal — when CVX shares open for trading on 8/19/25.

Registration Now Open for the Life Time Tropical 5K MIAMI , Aug. 15, 2025 /PRNewswire/ -- The 2026 Life Time Miami Marathon & Half presented by FP Movement has once again sold out – this time, two weeks sooner than the previous record sellout for last year's event, and just two weeks after registration opened to the public. Owned and produced by Life Time (NYSE: LTH), the nation's premier healthy lifestyle brand, registration for the January 25, 2026, event closed August 15 with 18,500 runners.

Does Consolidated Water (CWCO) have what it takes to be a top stock pick for momentum investors? Let's find out.

ISG (III) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

T. Rowe (TROW) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).